Literature DB >> 15937493

A single amino acid residue can determine the sensitivity of SERCAs to artemisinins.

Anne-Catrin Uhlemann1, Angus Cameron, Ursula Eckstein-Ludwig, Jorge Fischbarg, Pavel Iserovich, Felipe A Zuniga, Malcolm East, Anthony Lee, Leo Brady, Richard K Haynes, Sanjeev Krishna.   

Abstract

Artemisinins are the most important class of antimalarial drugs. They specifically inhibit PfATP6, a SERCA-type ATPase of Plasmodium falciparum. Here we show that a single amino acid in transmembrane segment 3 of SERCAs can determine susceptibility to artemisinin. An L263E replacement of a malarial by a mammalian residue abolishes inhibition by artemisinins. Introducing residues found in other Plasmodium spp. also modulates artemisinin sensitivity, suggesting that artemisinins interact with the thapsigargin-binding cleft of susceptible SERCAs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15937493     DOI: 10.1038/nsmb947

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  92 in total

1.  Genetic predisposition favors the acquisition of stable artemisinin resistance in malaria parasites.

Authors:  Dorothee Beez; Cecilia P Sanchez; Wilfred D Stein; Michael Lanzer
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

2.  Spontaneous mutations in the Plasmodium falciparum sarcoplasmic/ endoplasmic reticulum Ca2+-ATPase (PfATP6) gene among geographically widespread parasite populations unexposed to artemisinin-based combination therapies.

Authors:  Kazuyuki Tanabe; Sedigheh Zakeri; Nirianne Marie Q Palacpac; Manada Afsharpad; Milijaona Randrianarivelojosia; Akira Kaneko; Aung Swi Prue Marma; Toshihiro Horii; Toshihiro Mita
Journal:  Antimicrob Agents Chemother       Date:  2010-10-18       Impact factor: 5.191

3.  Reappraising the effects of artemisinin on the ATPase activity of PfATP6 and SERCA1a E255L expressed in Xenopus laevis oocytes.

Authors:  Stéphanie David-Bosne; Michael Voldsgaard Clausen; Hanne Poulsen; Jesper Vuust Møller; Poul Nissen; Marc le Maire
Journal:  Nat Struct Mol Biol       Date:  2016-01       Impact factor: 15.369

Review 4.  Transporters involved in resistance to antimalarial drugs.

Authors:  Stephanie G Valderramos; David A Fidock
Journal:  Trends Pharmacol Sci       Date:  2006-09-25       Impact factor: 14.819

5.  Artemisinins inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense in vitro growth.

Authors:  Yuliya V Mishina; Sanjeev Krishna; Richard K Haynes; John C Meade
Journal:  Antimicrob Agents Chemother       Date:  2007-03-05       Impact factor: 5.191

6.  Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India.

Authors:  Pabitra Saha; Subhasish K Guha; Sonali Das; Shrabanee Mullick; Swagata Ganguly; Asit Biswas; Dilip K Bera; Gaurangadeb Chattopadhyay; Madhusudan Das; Pratip K Kundu; Krishnangshu Ray; Ardhendu K Maji
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

7.  Artemisinin induces calcium-dependent protein secretion in the protozoan parasite Toxoplasma gondii.

Authors:  Kisaburo Nagamune; Wandy L Beatty; L David Sibley
Journal:  Eukaryot Cell       Date:  2007-08-31

8.  Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression.

Authors:  C Riganti; S Doublier; D Viarisio; E Miraglia; G Pescarmona; D Ghigo; A Bosia
Journal:  Br J Pharmacol       Date:  2009-03-09       Impact factor: 8.739

Review 9.  Recent advances in artemisinin production through heterologous expression.

Authors:  Patrick R Arsenault; Kristin K Wobbe; Pamela J Weathers
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

10.  Artemisinin resistance in Plasmodium falciparum: A process linked to dormancy?

Authors:  Qin Cheng; Dennis E Kyle; Michelle L Gatton
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-01-27       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.